South & Central America Human Microbiome Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

September 2025 | 128 pages | ID: SBCD4D499E62EN
The Insight Partners

Abstracts

The human microbiome market in South and Central America is projected to grow significantly, reaching approximately USD 147.22 million by 2031, up from USD 39.65 million in 2023, with an impressive compound annual growth rate (CAGR) of 17.8% during this period.

Executive Summary and Market Analysis

The market is divided into key regions: Brazil, Argentina, and the Rest of South and Central America. The growth of the human microbiome market in this region is supported by well-established healthcare systems, increased government support, and a rise in research and development activities. Additionally, the rising incidence of chronic diseases and the adoption of unhealthy lifestyles are expected to drive demand for microbiome-related products and services.

Market Segmentation

The South and Central America human microbiome market can be segmented based on type, application, and disease type:
- Type: The market is categorized into products and software/services, with products dominating the market share in 2023. The product segment includes probiotics and prebiotics.
- Application: The market is further divided into therapeutics, diagnostics, and research, with therapeutics holding the largest market share in 2023.
- Disease Type: The market is segmented into obesity, diabetes, autoimmune disorders, cancer, gastrointestinal (GIT) issues, and others, with GIT issues leading the market in 2023.

Market Outlook

The human microbiome's potential to revolutionize healthcare has led to increased investments in research and development. The microbiome, consisting of trillions of microorganisms, plays a crucial role in maintaining health and preventing diseases. Biotech startups and pharmaceutical companies are heavily investing in microbiome-based therapies. For instance, Xome Life Sciences, a pioneering microbiome startup in India, is developing diagnostic and therapeutic tools aimed at improving health outcomes.

A notable example of microbiome innovation is the FDA-approved treatment by Seres Therapeutics for recurrent Clostridium difficile infections, showcasing the therapeutic potential of microbiome-based drugs. Companies like Vedanta Biosciences are also raising significant funds to develop immunotherapies derived from microbiomes for conditions such as autoimmune disorders and cancer. Investors like Seventure Partners and Flagship Pioneering are increasingly funding microbiome data analysis companies, highlighting the growing recognition of the microbiome's importance in health. This surge in investment is expected to drive advancements in precision medicine and therapeutic solutions, creating numerous opportunities in the market.

Country Insights

The South and Central America human microbiome market is primarily composed of Brazil, Argentina, and other countries in the region, with Brazil holding the largest market share in 2023. A recent study published in the Brazilian Journal of Infectious Diseases highlighted the analysis of the sputum microbiome in cystic fibrosis patients, revealing a high presence of Burkholderia cepacia complex (Bcc). This research could lead to improved diagnostic methods and treatments for chronic diseases, thereby increasing the demand for microbiome solutions in Brazil.

Pharmaceutical companies and biotech startups are actively investing in innovative microbiome therapeutics, leading to the development of new products. For example, in April 2023, Nintx, a startup based in S?o Paulo, Brazil, collaborated with federal institutions and private companies to create new drugs from plant-based natural products, receiving a USD 3 million investment from Pitanga venture capital in 2022 to accelerate their market entry. This trend of increasing research and investment is propelling the growth of the human microbiome market in Brazil.

Company Profiles

Key players in the human microbiome market include MaaT Pharma, Ferring Holdings SA, AOBiome Therapeutics Inc, Finch Therapeutics Group Inc, Seres Therapeutics Inc, Merck & Co Inc, Rebiotix, Inc., Yakult Honsha Co., Ltd., IFF Nutrition & Biosciences, and Synthetic Biologics, Inc. These companies are employing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase their market presence.

Reason to buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America human microbiome market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the South & Central America human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America human microbiome market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

Companies

• MaaT Pharma
• Ferring Holdings SA
• AOBiome Therapeutics Inc
• Finch Therapeutics Group Inc
• Seres Therapeutics Inc
• Merck & Co Inc
• Rebiotix, Inc.
• Yakult Honsha Co., Ltd.
• IFF Nutrition & Biosciences
• Synthetic Biologics, Inc.

Contents

1. INTRODUCTION

1.1 Report Guidance
1.2 Market Segmentation

2. EXECUTIVE SUMMARY

2.1 Key Insights

3. RESEARCH METHODOLOGY

3.1 Secondary Research
3.2 Primary Research
  3.2.1 Hypothesis formulation:
  3.2.2 Macroeconomic factor analysis:
  3.2.3 Developing base number:
  3.2.4 Data Triangulation:
  3.2.5 Country-level data:

4. SOUTH & CENTRAL AMERICA HUMAN MICROBIOME MARKET - KEY MARKET DYNAMICS

4.1 Market Drivers
  4.1.1 Significant Investments by Key Market Players
  4.1.2 Government Initiatives
4.2 Market Restraints
  4.2.1 Challenges During Production of Microbiome
4.3 Market Opportunities
  4.3.1 Robust Investment in Research and Development
4.4 Future Trends
  4.4.1 Emergence of Precision Medicine
4.5 Impact of Drivers and Restraints:

5. HUMAN MICROBIOME MARKET - SOUTH & CENTRAL AMERICA ANALYSIS

5.1 South & Central America Human Microbiome Market Revenue (US$ Million), 2021-2031
5.2 South & Central America Human Microbiome Market Forecast Analysis

6. SOUTH & CENTRAL AMERICA HUMAN MICROBIOME MARKET ANALYSIS - BY TYPE

6.1 Product
  6.1.1 Overview
  6.1.2 Product: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.2 Software and Services
  6.2.1 Overview
  6.2.2 Software and Services: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. SOUTH & CENTRAL AMERICA HUMAN MICROBIOME MARKET ANALYSIS - BY APPLICATION

7.1 Therapeutics
  7.1.1 Overview
  7.1.2 Therapeutics: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Diagnostics
  7.2.1 Overview
  7.2.2 Diagnostics: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Research
  7.3.1 Overview
  7.3.2 Research: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. SOUTH & CENTRAL AMERICA HUMAN MICROBIOME MARKET ANALYSIS - BY DISEASE TYPE

8.1 Obesity
  8.1.1 Overview
  8.1.2 Obesity: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Diabetes
  8.2.1 Overview
  8.2.2 Diabetes: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Autoimmune Disorder
  8.3.1 Overview
  8.3.2 Autoimmune Disorder: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Cancer
  8.4.1 Overview
  8.4.2 Cancer: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 GIT
  8.5.1 Overview
  8.5.2 GIT: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
  8.6.1 Overview
  8.6.2 Others: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. SOUTH & CENTRAL AMERICA HUMAN MICROBIOME MARKET - COUNTRY ANALYSIS

9.1 South & Central America
  9.1.1 South & Central America Human Microbiome Market - Revenue and Forecast Analysis - by Country
    9.1.1.1 South & Central America Human Microbiome Market - Revenue and Forecast Analysis - by Country
    9.1.1.2 Brazil: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
      9.1.1.2.1 Brazil: South & Central America Human Microbiome Market Share - by Type
      9.1.1.2.2 Brazil: South & Central America Human Microbiome Market Share - by Product
      9.1.1.2.3 Brazil: South & Central America Human Microbiome Market Share - by Application
      9.1.1.2.4 Brazil: South & Central America Human Microbiome Market Share - by Disease Type
    9.1.1.3 Argentina: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
      9.1.1.3.1 Argentina: South & Central America Human Microbiome Market Share - by Type
      9.1.1.3.2 Argentina: South & Central America Human Microbiome Market Share - by Product
      9.1.1.3.3 Argentina: South & Central America Human Microbiome Market Share - by Application
      9.1.1.3.4 Argentina: South & Central America Human Microbiome Market Share - by Disease Type
    9.1.1.4 Rest of South & Central America: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
      9.1.1.4.1 Rest of South & Central America: South & Central America Human Microbiome Market Share - by Type
      9.1.1.4.2 Rest of South & Central America: South & Central America Human Microbiome Market Share - by Product
      9.1.1.4.3 Rest of South & Central America: South & Central America Human Microbiome Market Share - by Application
      9.1.1.4.4 Rest of South & Central America: South & Central America Human Microbiome Market Share - by Disease Type

10. COMPETITIVE LANDSCAPE

10.1 Heat Map Analysis by Key Players
10.2 Company Positioning and Concentration

11. INDUSTRY LANDSCAPE

11.1 Overview
11.2 Growth Strategies in the Human Microbiome Market
11.3 Organic Growth Strategies
  11.3.1 Overview
11.4 Inorganic Growth Strategies
  11.4.1 Overview

12. COMPANY PROFILES

12.1 MaaT Pharma
  12.1.1 Key Facts
  12.1.2 Business Description
  12.1.3 Products and Services
  12.1.4 Financial Overview
  12.1.5 SWOT Analysis
  12.1.6 Key Developments
12.2 Ferring Holdings SA
  12.2.1 Key Facts
  12.2.2 Business Description
  12.2.3 Products and Services
  12.2.4 Financial Overview
  12.2.5 SWOT Analysis
  12.2.6 Key Developments
12.3 AOBiome Therapeutics Inc
  12.3.1 Key Facts
  12.3.2 Business Description
  12.3.3 Products and Services
  12.3.4 Financial Overview
  12.3.5 SWOT Analysis
  12.3.6 Key Developments
12.4 Finch Therapeutics Group Inc
  12.4.1 Key Facts
  12.4.2 Business Description
  12.4.3 Financial Overview
  12.4.4 SWOT Analysis
  12.4.5 Key Developments
12.5 Seres Therapeutics Inc
  12.5.1 Key Facts
  12.5.2 Business Description
  12.5.3 Products and Services
  12.5.4 Financial Overview
  12.5.5 SWOT Analysis
  12.5.6 Key Developments
12.6 Merck & Co Inc
  12.6.1 Key Facts
  12.6.2 Business Description
  12.6.3 Products and Services
  12.6.4 Financial Overview
  12.6.5 SWOT Analysis
  12.6.6 Key Developments
12.7 Yakult Honsha Co., Ltd.
  12.7.1 Key Facts
  12.7.2 Business Description
  12.7.3 Products and Services
  12.7.4 Financial Overview
  12.7.5 SWOT Analysis
  12.7.6 Key Developments
12.8 Rebiotix, Inc.
  12.8.1 Key Facts
  12.8.2 Business Description
  12.8.3 Products and Services
  12.8.4 Financial Overview
  12.8.5 SWOT Analysis
  12.8.6 Key Developments
12.9 IFF Nutrition & Biosciences
  12.9.1 Key Facts
  12.9.2 Business Description
  12.9.3 Products and Services
  12.9.4 Financial Overview
  12.9.5 SWOT Analysis
  12.9.6 Key Developments
12.10 Synthetic Biologics, Inc.
  12.10.1 Key Facts
  12.10.2 Business Description
  12.10.3 Products and Services
  12.10.4 Financial Overview
  12.10.5 SWOT Analysis
  12.10.6 Key Developments

13. APPENDIX

13.1 About Us
13.2 List of Abbreviations

List Of Tables

LIST OF TABLES
Table 1. South & Central America Human Microbiome Market Segmentation
Table 2. South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Table 3. South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
Table 4. South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
Table 5. South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Disease Type
Table 6. South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
Table 7. Brazil: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 8. Brazil: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 9. Brazil: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Brazil: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type
Table 11. Argentina: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 12. Argentina: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 13. Argentina: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 14. Argentina: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type
Table 15. Rest of South & Central America: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 16. Rest of South & Central America: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 17. Rest of South & Central America: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 18. Rest of South & Central America: South & Central America Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type
Table 19. Recent Organic Growth Strategies in the Human Microbiome Market
Table 20. Recent Inorganic Growth Strategies in the Human Microbiome Market
Table 21. List of Abbreviations

List Of Figures

LIST OF FIGURES
Figure 1. South & Central America Human Microbiome Market Segmentation - Country
Figure 2. South & Central America Human Microbiome Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Human Microbiome Market Revenue (US$ Million), 2021-2031
Figure 5. South & Central America Human Microbiome Market Share (%) - by Type (2023 and 2031)
Figure 6. Product: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 7. Software and Services: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 8. South & Central America Human Microbiome Market Share (%) - by Application (2023 and 2031)
Figure 9. Therapeutics: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 10. Diagnostics: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 11. Research: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 12. South & Central America Human Microbiome Market Share (%) - by Disease Type (2023 and 2031)
Figure 13. Obesity: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 14. Diabetes: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 15. Autoimmune Disorder: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 16. Cancer: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 17. GIT: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 18. Others: South & Central America Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 19. South & Central America Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 20. Brazil: South & Central America Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 21. Argentina: South & Central America Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 22. Rest of South & Central America: South & Central America Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 23. Heat Map Analysis by Key Players
Figure 24. Company Positioning and Concentration
Figure 25. Growth Strategies in the Human Microbiome Market